Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$0.75 - $1.1 $11,151 - $16,354
-14,868 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$0.96 - $1.74 $14,273 - $25,870
14,868 New
14,868 $16,000
Q4 2020

Feb 11, 2021

SELL
$0.76 - $1.47 $9,570 - $18,511
-12,593 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$0.67 - $0.96 $8,437 - $12,089
12,593 New
12,593 $10,000
Q4 2019

Feb 10, 2020

SELL
$0.63 - $2.27 $12 - $45
-20 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$0.79 - $1.11 $53,426 - $75,067
-67,628 Reduced 99.97%
20 $0
Q1 2019

May 15, 2019

BUY
$0.6 - $1.41 $40,588 - $95,383
67,648 New
67,648 $74,000
Q3 2018

Nov 14, 2018

SELL
$0.35 - $0.92 $350 - $920
-1,000 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$0.42 - $0.74 $5,300 - $9,338
-12,620 Reduced 92.66%
1,000 $0
Q1 2018

May 15, 2018

BUY
$0.76 - $1.32 $2,470 - $4,291
3,251 Added 31.35%
13,620 $11,000
Q4 2017

Feb 14, 2018

BUY
$1.1 - $1.54 $10,059 - $14,083
9,145 Added 747.14%
10,369 $12,000
Q3 2017

Nov 14, 2017

BUY
$1.19 - $1.43 $1,456 - $1,750
1,224
1,224 $2,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $143M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.